Press Releases Year All News | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Jul 01, 2022 TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 27, 2022 TCR² Therapeutics Appoints Industry and Finance Veteran Eric Sullivan as Chief Financial Officer Jun 01, 2022 TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 01, 2022 TCR² Therapeutics to Participate in Two Upcoming Conferences in June May 12, 2022 TCR² Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update May 02, 2022 TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 01, 2022 TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 22, 2022 TCR² Therapeutics Reports Fourth Quarter 2021 Financial Results and Provides Corporate Update Mar 08, 2022 TCR² Therapeutics to Highlight Off-the-Shelf TRuC-T Cell at the American Association of Cancer Research Annual Meeting 2022 Mar 04, 2022 TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pagination Current page 1 Page 2 Next page next › Last page last »